Portero-Otin M, Nagaraj R H, Monnier V M
Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106.
Biochim Biophys Acta. 1995 Feb 22;1247(1):74-80. doi: 10.1016/0167-4838(94)00209-y.
Pyrraline (epsilon-2-(formyl-5-hydroxymethyl-pyrrol-1-yl)-L-norleucine) is an advanced Maillard reaction product formed from 3-deoxyglucosone in the non-enzymatic reaction between glucose and the epsilon-amino group of lysine residues on proteins. Although its presence in vivo as well as in in vitro incubations of proteins with sugars has been documented by immunochemical methods using polyclonal and monoclonal antibodies, its formation in proteins has recently been questioned by similar methodology. To clarify this issue, we investigated pyrraline formation in proteins following alkaline hydrolysis and quantitation by high-performance liquid chromatography on a C18 reverse-phase column. Time- and sugar concentration-dependent increase in pyrraline formation was noted in serum albumin incubated with either 100 mM glucose or 50 mM 3-deoxyglucosone. Formation of pyrraline from 3-deoxyglucosone was rapid at slightly acidic pH, confirming its synthetic pathway through this Maillard reaction intermediate. Low levels of pyrraline (< 10 pmol/mg protein) were also detected in a pool of human skin collagen by this method, but no age effect was apparent. Using a slightly different approach, pyrraline-like material was detected in human plasma proteins following enzyme digestion and analysis by high performance liquid chromatography. Plasma from diabetic patients showed a significant increase in pyrraline-like material compared to controls. The levels in diabetic and normal individuals were 21.6 +/- 9.56 and 12.8 +/- 5.6 pmol per mg protein, respectively (P = 0.005), reflecting thereby the elevated levels of the immediate precursor of pyrraline, 3-deoxyglucosone, in diabetic plasma.
吡咯赖氨酸(ε-2-(甲酰基-5-羟甲基-吡咯-1-基)-L-正亮氨酸)是葡萄糖与蛋白质赖氨酸残基的ε-氨基在非酶促反应中由3-脱氧葡萄糖酮形成的晚期美拉德反应产物。尽管通过使用多克隆和单克隆抗体的免疫化学方法已证明其在体内以及蛋白质与糖的体外孵育中的存在,但最近通过类似方法对其在蛋白质中的形成提出了质疑。为了阐明这个问题,我们研究了碱性水解后蛋白质中吡咯赖氨酸的形成,并通过C18反相柱上的高效液相色谱法进行定量。在用100 mM葡萄糖或50 mM 3-脱氧葡萄糖酮孵育的血清白蛋白中,观察到吡咯赖氨酸形成随时间和糖浓度的增加。在略酸性pH下,由3-脱氧葡萄糖酮形成吡咯赖氨酸的速度很快,证实了其通过这种美拉德反应中间体的合成途径。通过该方法在一组人皮肤胶原蛋白中也检测到低水平的吡咯赖氨酸(<10 pmol/mg蛋白质),但未发现年龄效应。使用略有不同的方法,在酶消化并通过高效液相色谱分析后,在人血浆蛋白中检测到类吡咯赖氨酸物质。与对照组相比,糖尿病患者的血浆中类吡咯赖氨酸物质显著增加。糖尿病患者和正常个体的水平分别为每毫克蛋白质21.6±9.56和12.8±5.6 pmol(P = 0.005),从而反映出糖尿病血浆中吡咯赖氨酸的直接前体3-脱氧葡萄糖酮的水平升高。